To additionally evaluate the functionality of T progenies derived in vitro from their highly purified precursors, a cytotoxicity assay was performed using a lung cancer target cell line A549 or a mouse FcγR+P815 cells in the presence of mAbs specific for triggering receptors, in a redirected killing assay (reverse ADCC). The gene discussed is FCGR2A; the disease is lung cancer.